Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Biotech
China biotechs ‘reshaping’ US biopharma: Jefferies report
In 2025's Q1, 32% of outlicensing biotech deal value occurred in China versus 21% reported in both 2024 and 2023, according to Jefferies.
Gabrielle Masson
Jul 14, 2025 2:30pm
Merck wades deeper into HIV PrEP waters with pair of trials
Jul 14, 2025 1:12pm
Sponsored
How to get pharmaceutical treatments where they’re needed most.
Jul 14, 2025 8:00am
Research non-profit acquires embattled Essa in Xoma-backed deal
Jul 14, 2025 9:30am
Sponsored
Carl Sailer on AI, market trends, and strategic planning in biotech
Oct 28, 2024 8:00pm
Takeda narcolepsy blockbuster hopeful secures double ph. 3 wins
Jul 14, 2025 5:51am